Ranbaxy Generic Drugs Denied Import to U.S. by FDA

Filed in archive Consumer Alert , News by Gloria Gamat on September 16, 2008

The largest maker of generic drugs in India - Ranbaxy Laboratories Ltd - has been issued a warning letter and an import alert by the FDA in lieu of 30 generic drugs made in its two plants in India.

The two plants whose quality control issues in Ranbaxy's Dewas and Paonta Sahib plants in India.

The Warning Letters identify the agency's concerns about deviations from U.S. current Good Manufacturing Practice (cGMP) requirements at Ranbaxy's manufacturing facilities in Dewas and Paonta Sahib (including the Batamandi unit), in India. Because of the extent and nature of the violations, FDA today issued an Import Alert, under which U.S. officials may detain at the U.S. border, any active pharmaceutical ingredients (API) (the primary therapeutic component of a finished drug product) and both sterile and non-sterile finished drug products manufactured at these Ranbaxy facilities and offered for import into the United States.

The FDA said they will closely monitor and evaluate the situation. The list of 30 generic drugs affected can be found here.

Read more from the FDA News and the US News and World Report.

Related Entries:

Generic Allegra from Mylan Laboratories - 13 April 2006
Mylan Pharma's Generic Glipizide and Metformin Hydrochlorid... - 18 April 2007
Caraco Pharma's Generic Paxil®, Approved by the FDA - 08 July 2007
First Generic Risperdal (Risperidone), FDA-Approved - 05 July 2008

« American Medical Associat... | Main | Novel Prostate Cancer Tre... »

Permalink: Ranbaxy Generic Drugs Denied Import to U.S. by FDA

Tags: Ranbaxy Laboratories Ltd India pharmaceutical generic drug Import Alert Warning Letter FDA U.S. curr

Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/134028

Addthis

Ask

Blinklist

del.icio.us

Digg

Fark

Facebook

Google

Lycos

Ma.gnolia

Mr Wong

Netscape

Netvousz

Newsvine

StumbleUpon

Slashdot

Tailrank

Technorati

Wink

Yahoo

Vote for Ranbaxy Generic Drugs Denied Import to U.S. by FDA:

Currently 8.33/10
1
2
3
4
5
6
7
8
9
10

Rating: 8.33 out of 3 vote(s) cast.

Response from: Trusted.MD Network

Add your response to Ranbaxy Generic Drugs Denied Import to U.S. by FDA:

Name: *

Email: (will never be shown)*

URL:

(* marked fields are required)

Notify me if more comments appear?

Subscribe to Straightfromthedoc newsletter? (Newsletters are sent out weekly).

Remember me

Security Code: *
(Please help us to sort out spam.)

Please enter your comment here: (Sorry, no HTML is allowed - URLs will be made clickable automatically if you add http:// to your URL.)

We welcome your comments, however all comments are moderated. Offensive or off-topic comments will be deleted and not displayed.

Share It

Use the search to look for other interesting posts

Contributors (Last 90 days)

Gloria Gamat (5)
Ruth Schaffer (2)
Creative Weblogging (8)

This site has 1574 entries and is powered by Creative Weblogging since July 2005.

Our Editors recommend

Disclaimer

Some of the contents of this site are protected Creative Weblogging Inc. 2004-2010.

Check out our Sponsored Blogs!

Business Computer Blog (UK)

Are you interested in writing a blog in our network?

See which positions are currently open.

Testimonials

'Thanks, for a very interesting and informative Blog.'

'Thanks for doing this; it's a terrific site.'

'I don't know...but why I don't find such informative and profitable blogs so often, I suspect blogging world is becoming so small that we can't find such lucrative blogs like this one.'